Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamal Majidpoor

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Clinical Immunology (Orlando, Fla.)|March 4, 2021
The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectivesJamal Majidpoor, Keywan Mortezaee
Cellular Oncology (Dordrecht, Netherlands)|April 9, 2021
Angiogenesis as a hallmark of solid tumors - clinical perspectivesJamal Majidpoor, Keywan Mortezaee
International Reviews of Immunology|July 6, 2022
Dysregulated metabolism: A friend-to-foe skewer of macrophagesKeywan Mortezaee, Jamal Majidpoor
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 15, 2021
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applicationsJamal Majidpoor, Keywan Mortezaee
Frontiers in Immunology|April 18, 2022
CD8<sup>+</sup> T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical PerspectivesKeywan Mortezaee, Jamal Majidpoor
Cancer Medicine|March 18, 2022
Checkpoint inhibitor/interleukin-based combination therapy of cancerKeywan Mortezaee, Jamal Majidpoor
Journal of Cellular and Molecular Medicine|January 10, 2023
Transforming growth factor-β signalling in tumour resistance to the anti-PD-(L)1 therapy: UpdatedKeywan Mortezaee, Jamal Majidpoor
Medical Oncology (Northwood, London, England)|June 18, 2022
NK and cells with NK-like activities in cancer immunotherapy-clinical perspectivesKeywan Mortezaee, Jamal Majidpoor
Medical Oncology (Northwood, London, England)|March 25, 2023
The impact of hypoxia on extracellular vesicle secretome profile of cancerKeywan Mortezaee, Jamal Majidpoor
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 17, 2026
Retraction notice to "Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications" [Biomedicine & Pharmacotherapy 145 (2022) 112419]Jamal Majidpoor, Keywan Mortezaee
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Clinical Immunology (Orlando, Fla.)|March 4, 2021
The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectivesJamal Majidpoor, Keywan Mortezaee
Cellular Oncology (Dordrecht, Netherlands)|April 9, 2021
Angiogenesis as a hallmark of solid tumors - clinical perspectivesJamal Majidpoor, Keywan Mortezaee
International Reviews of Immunology|July 6, 2022
Dysregulated metabolism: A friend-to-foe skewer of macrophagesKeywan Mortezaee, Jamal Majidpoor
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 15, 2021
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applicationsJamal Majidpoor, Keywan Mortezaee
Frontiers in Immunology|April 18, 2022
CD8<sup>+</sup> T Cells in SARS-CoV-2 Induced Disease and Cancer-Clinical PerspectivesKeywan Mortezaee, Jamal Majidpoor
Cancer Medicine|March 18, 2022
Checkpoint inhibitor/interleukin-based combination therapy of cancerKeywan Mortezaee, Jamal Majidpoor
Journal of Cellular and Molecular Medicine|January 10, 2023
Transforming growth factor-β signalling in tumour resistance to the anti-PD-(L)1 therapy: UpdatedKeywan Mortezaee, Jamal Majidpoor
Medical Oncology (Northwood, London, England)|June 18, 2022
NK and cells with NK-like activities in cancer immunotherapy-clinical perspectivesKeywan Mortezaee, Jamal Majidpoor
Medical Oncology (Northwood, London, England)|March 25, 2023
The impact of hypoxia on extracellular vesicle secretome profile of cancerKeywan Mortezaee, Jamal Majidpoor
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 17, 2026
Retraction notice to "Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications" [Biomedicine & Pharmacotherapy 145 (2022) 112419]Jamal Majidpoor, Keywan Mortezaee
Pageof 8